Pace® Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025
Company expands sterile fill-finish services, capacity for biologics development and manufacturing, and more. Minneapolis, MN – January 10, 2025 – Pace® Life Sciences, LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of Pace®, a Science and Technology Company, today announced significant growth plans for two of the company’s locations. Pace® Life […]